Actively Recruiting

Phase Not Applicable
Age: 0 - 21Years
All Genders
ID06322654

A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA Patients: Single-center, Randomized, Single-blinded, Comparative Study of a Robotically Active Verticalization Model Versus Robotically Assisted Locomotion Model

Led by Wiktor Dega University Orthopedic and Rehabilitation Hospital · Updated on 2024-03-21

200

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are comparing two models of robotically assisted rehabilitation to find the best approach for people with spinal muscular atrophy (SMA) aged 0 to 21 years. This single-center, randomized, single-blinded study aims to determine which rehabilitation model works better depending on the patient's age and starting physical abilities. The study plans to include 200 patients, with 100 in each rehabilitation group. The study involves two rehabilitation methods: Robotically Assisted Verticalization and Robotically Assisted Locomotion. Both approaches include motor control training, locomotion with balance and coordination exercises, verticalization training using standing frame devices, and cognitive therapy. The trial will last for up to 4 years, with patients randomly assigned to one of the two rehabilitation groups. Participants will undergo regular clinical assessments using several tests including the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders, motor function scales, gait and balance tests, and imaging of the spine and hip joints. Quality of life for patients and their caregivers will also be evaluated. These assessments occur every six months for up to 2.5 years. The study will monitor hospitalizations, discomfort during therapy, and fracture occurrences throughout the trial period.

CONDITIONS

Brief Title

A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA (Spinal Muscular Atrophy) Patients

Who Can Participate

Age: 0 - 21Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signing informed consent by participant or legal guardian
  • Genetic diagnosis of spinal muscular atrophy types 1-4, symptomatic or pre-symptomatic
  • Age between 0 and 21 years at study start
  • Receiving treatment under a drug program for spinal muscular atrophy
Not Eligible

You will not qualify if you...

  • Cardio-respiratory disorders requiring invasive ventilation
  • Advanced osteoporosis with multiple fractures before treatment
  • Functional deterioration during rehabilitation as measured by relevant SMA scales
  • Lack of cooperation with therapist
  • Other functional conditions preventing exercise

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 2.5 years

Participants receive robotically assisted rehabilitation through either the Locomotion model or the Verticalization model, including motor control training, balance and coordination exercises, verticalization training, and cognitive therapy.

Rehabilitation sessions every 6 months

Follow-up

Duration - Up to 2.5 years

Participants undergo clinical and functional assessments, imaging, and quality of life evaluations up to 2.5 years after treatment start to monitor progress and safety.

Assessments every 6 months; imaging once per year

Trial Site Locations

Total: 1 location

1

Wiktor Dega University Orthopedic and Rehabilitation Hospital

Poznan, Poland, 61-545

Actively Recruiting

Loading map...

Research Team

M

Marek Jóźwiak

R

Radosław Rutkowski

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Phase 2, Double-Blind Study to Evaluate the Pharmacokineti...

Spinal Muscular Atrophy

Actively Recruiting

25 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here